Related Experiment Video
Updated: Jun 6, 2026
08:18
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1
M Thai1, P Y Ting, J McLaughlin
1Department of Biological Chemistry, Molecular Biology Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Leukemia
|November 25, 2010
Summary
RIN1 protein regulates BCR-ABL1 kinase activity, crucial for leukemia development. Targeting RIN1 could offer new treatments for imatinib-resistant chronic myeloid leukemia.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- ABL gene translocations drive leukemogenesis by creating active tyrosine kinases.
- Leukemic fusion proteins retain autoinhibitory domains, suggesting regulatory mechanisms exist.
- The paradox of active kinases with inhibitory domains requires explanation.
Purpose of the Study:
- To identify regulatory mechanisms of BCR-ABL1 kinase activity.
- To investigate the role of RIN1 in BCR-ABL1-driven leukemogenesis.
- To explore RIN1 as a therapeutic target in ABL-translocated leukemias.
Main Methods:
- Investigated BCR-ABL1 activity modulation by RIN1 overexpression and silencing.
- Assessed transformation of Rin1(-/-) bone marrow cells by various ABL fusion proteins.
- Evaluated the effect of RIN1 manipulation on imatinib sensitivity.
Main Results:
- RIN1 overexpression increased BCR-ABL1 activity; RIN1 silencing decreased it.
- Rin1(-/-) bone marrow cells resisted transformation by BCR-ABL1 and its mutants.
- RIN1 silencing enhanced sensitivity to imatinib, suggesting RIN1 stabilizes an active BCR-ABL1 conformation.
- RIN1 acts cell-autonomously to collaborate with BCR-ABL1 in transformation.
Conclusions:
- RIN1 is a key regulator of BCR-ABL1 kinase activity and leukemic transformation.
- Targeting RIN1 presents a novel therapeutic strategy for ABL-translocated leukemias, including imatinib-resistant cases.
- RIN1 inhibition may synergize with existing ABL kinase inhibitors.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...